Lallemand-Biotec Pharmacon

Lallemand is a global leader in the development, production, and marketing of yeast, bacteria, and specialty ingredients. Its specialized division, Lallemand Health Solutions, focuses on the manufacturing of probiotic bacteria and yeast for the human health market, covering everything from lab to shelf. In 2020, Lallemand acquired the Biotec BetaGlucans subsidiary from Biotec Pharmacon (now ArcticZymes Technologies), integrating high-purity beta-glucans into its portfolio for pharmaceutical and nutraceutical applications. The company operates multiple GMP-certified manufacturing facilities and research centers dedicated to microbiome science and live biotherapeutic products.